Community Practice

FDA issues new information on varenicline (Chantix, Pfizer)

92 new products in development for HIV/AIDS

Fougera donates topical steroids and antibiotics to countries in need via AmeriCares

Schering-Plough/Organon merger passes antitrust scrutiny and is completed

Many Medicare Part D patients will find fewer drugs to choose from in their drug plans' formularies in 2008

Seroquel XR from AstraZeneca has gained a new indication: for maintenance treatment of schizophrenia in adults

DEA has released its final rule allowing doctors to give patients multiple prescriptions for up to a 90-day supply of Schedule II narcotics

Mother sues drugmakers over son's cold medication death

Nexavar gains new indication approval for liver cancer

The American Society of Consultant Pharmacists has selected PharmMD Solutions as a medication therapy management provider partner

FDA says product contains unapproved drug and could damage eye

Pharmacy schools' emphasis on chemistry is unjustified, according to this community pharmacist.

New products include brand-name drugs, generics, home-health products, over-the-counter, and health and beauty care.

Transparency in Pharmaceutical Purchasing Solutions: The HR Policy Association's Pharmaceutical Purchasing Coalition has 13 PBMs agreeing to five criteria creating pricing transparency for certification.

Peggy Memoli is recognized for her work with Alzheimer's patients. She is one of three recipients of 2007 Eisai award recognizing the role of pharmacists in Alzheimer's care.

While boards of pharmacy are becoming less punitive in punishing addicted pharmacists, treatment options still vary from state to state.

Druggists Circular and Drug Topics published The Red Book for close to 100 years to provide key drug pricing data to pharmacists.

According to the American Association of Colleges of Pharmacy pharmacy schools are growing despite increased oversight and a pending faculty shortage.

Raltegravir, a new drug that inhibits integrase, the enzyme responsible for the insertion of HIV DNA into human DNA, was granted accelerated approval by the FDA.

Hospitals will not have to deduct pharmacy overhead costs from drug acquisition costs on Medicare claims, nor will they have to report overhead charges as a separate billing line item. However, CMS refused to back off its proposal to cut the 2008 reimbursement rate for all separately payable drugs.

Lower dose of dasatinib (Sprycel) approved.

This drug combines an antihistamine with a nasal decongestant.

Aripiprazole is approved by FDA for schizophrenia in adolescents.

NACDS and NCPA sue CMS to stop implementation of the average manufacturer price rule.

Outcomes Pharmaceutical Health Care and the American Society of Consultant Pharmacists to jointly focus on increasing access to MTM services

FDA warns of potential cefepime safety risk

Health Net of Connecticut is being criticized for sending misleading electronic messages to pharmacists that improperly denied coverage for low-income children

CMS has introduced a new tool for comparing Medicare Part D drug plans, but critics contend that it is still a confusing process

Tasigna (nilotinib) received FDA approval for chronic myeloid leukemia (CML) in adult patients who are resistant to other therapies.

Updated guidelines address tumors arising in the lip, oral cavity, oropharynx, hypopharynx, glottic and supraglottic larynx, paranasal sinuses, nasopharynx, and salivary glands.